Riding the realty wave!

IIPM - Admission Procedure

Here’s your pass to the party...

Many gaped in awe at the newspaper headline which read that Connaught Place has now jostled its way to the top ten list, as the seventh most expensive office centre in the world, just behind Nariman Point, Mumbai. Great stuff, but the retail investor has almost always been left out of the real estate party, even as prices continue to cross one milestone after another. The reason is simple; most investors feel handicapped when it comes to real estate investments because of huge capital requirements. But there are affordable ways too...

Of course, there is the most-popular stock market route, wherein one can invest in existing listed stocks like that of Unitech and Parsvanath, which are currently hovering much below their peak. Then there are also upcoming IPOs like that of DLF which would definitely feature on the investor’s radar, yet rest assured that there are better times ahead. But, in the offing are a few more ways that’ll allow investors to drop in and ride the real estate wave.

The new investment options to soon become available to the retail investor are Real Estate Mutual Funds and Real Estate Investment Trusts (REIT). While the option of investing via Mutual Funds will allow investors to reap the returns of a real estate boom, in a relatively secure way, and under professional guidance; Real Estate Investment Trusts – publicly traded Trusts making investments in real estate assets – may also soon become a reality option to exercise.

Says Ashwin Ramesh, Co-founder, Primary Real Estate Advisors, “Mutual funds and REITs are the safest route for an investor to get an exposure in real estate. Even though both the options are not available for the Indian retail investor presently, the SEBI is working towards it and soon we may see retail investor participation in both these avenues.”

Edit bureau: Bikram Keshari Jena

For Complete IIPM Article, Click on IIPM Article

Source : IIPM Editorial, 2008

An IIPM and Professor Arindam Chaudhuri (Renowned Management Guru and Economist) Initiative

For More IIPM Info, Visit Below....
IIPM - Admission Procedure
Why Study Abroad When IIPM Gives You 3 global Advantages!
The Sunday Indian - India's Greatest News weekly
IIPM, ADMISSIONS FOR NEW DELHI & GURGAON BRANCHES
IIPM, GURGAON
ARINDAM CHAUDHURI’S 4 REASONS WHY YOU SHOULD CHOOSE IIPM...
IIPM Economy Review

Are you ‘triskaidekaphobic’?

IIPM - Admission Procedure

...we mean, should Ranbaxy fear No.13?

‘India Inc. going global’ no more sounds astounding! And why should it, when on one hand India Inc. is firing all cylinders, on the other, foreign money is flowing in like it never did! And so it has increased the appetite of hungry-forpower India Inc., which after shelling out a monumental $24.3 billion in buying out foreign companies during the first four months of 2007 alone is scouting greedily for more! Look at Ranbaxy which gobbled-up 13 skin-care brands from the stable of the renowned American pharmaceutical major Bristol-Myers Squibb (BMS) on May 28, 2007 at one go. While speaking on the deal, a Ranbaxy spokesperson told 4Ps B&M, “The acquisition will strengthen our dermatology range. Earlier we had one product but now we will have a wider range with a greater market penetration capability. Currently our plans are to market the products in high margin markets like USA, with no plans for India yet.”

The acquisition is believed to have stemmed from Ranbaxy’s long term strategy of product portfolio expansion to garner a larger pie of the lucrative market of dermatology products. Renowned for its cost effective distribution channels, the acquisition is sure to propel Ranbaxy’s brand potential ahead, from the doldrums it seems to been in off late. It is estimated that the combined market value of the brands is close to $4.5 billion with sales hovering around $15 million.

However, Ranbaxy despite having paid a ‘lower than valued’ amount has to watch out as ‘all’ 13 brands come under the purlieu of ‘branded generic drugs’ – simply meaning that they either have already lost or will lose their patent shortly and then can be manufactured and marketed by all generic manufacturers. Hence, while the deal gives Ranbaxy a chance to get stronger in the dermatology drug market, it may have just placed its bet on a winning horse which has now gotten old! 4Ps

Edit bureau: Karan Mehrishi

For Complete IIPM Article, Click on IIPM Article

Source : IIPM Editorial, 2008

An IIPM and Professor Arindam Chaudhuri (Renowned Management Guru and Economist) Initiative

For More IIPM Info, Visit Below....

IIPM - Admission Procedure
Why Study Abroad When IIPM Gives You 3 global Advantages!
The Sunday Indian - India's Greatest News weekly
IIPM, ADMISSIONS FOR NEW DELHI & GURGAON BRANCHES
IIPM, GURGAON
ARINDAM CHAUDHURI’S 4 REASONS WHY YOU SHOULD CHOOSE IIPM...